公开(公告)号：US20230295175A1

公开(公告)日：2023-09-21

申请号：US18122892

申请日：2023-03-17

Applicant: ENANTA PHARMACEUTICALS, INC.

Inventor： Kaicheng Zhu ,  Tao Wang ,  Xin Zhang ,  Xiaowen Peng ,  Ruichao Shen ,  Jiajun Zhang ,  Wei Li ,  Hui Cao ,  Xuri Gao ,  Guoqiang Wang ,  George G. Wu ,  Yat Sun Or

IPC: C07D487/10

CPC classification number: C07D487/10

Abstract: The present invention relates to processes for preparing a compound of Formula (A):




or a pharmaceutically acceptable salt or solvate thereof. Compound of Formula (A) and pharmaceutical compositions are useful as SARS-CoV-2 3CL pro inhibitors.